(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
On March 10, 2014, Wendell Wierenga, Ph.D. was appointed to serve as a Class III
director of Apricus Biosciences, Inc. (the "Company"). In connection with his
appointment as a director, Dr. Wierenga was awarded a stock option grant for
100,000 shares of the Company's common stock under the Company's 2012 Stock Long
Term Incentive Plan.
Item 8.01 Other Events.
On March 10, 2014, the Company provided an update to its corporate presentation.
The presentation is currently available on the Company's website and filed
herewith as Exhibit 99.1.